SquamousCellCarcinomaofSkin near Elmhurst, NY

Biography: Dr. Lipner is an Associate Professor of Clinical Dermatology, Associate Attending Physician, and Director of the Nail Division at the New York-Presbyterian Hospital/Weill Cornell Medical Center. She completed her undergraduate studies at Dartmouth College where she obtained a Bachelor of Arts in Chemistry and graduated Phi Beta Kappa and Summa Cum Laude. Dr. Lipner completed her medical training at Albert Einstein College of Medicine, where she received both M.D. and Ph.D degrees and graduated Alpha Omega Alpha. She completed her residency training in Dermatology at the New York-Presbyterian Hospital/Weill Cornell Medical Center.Dr. Lipner is a member of the American Academy of Dermatology, Women's Dermatologic Society, and Council for Nail Disorders, American Dermatologic Association, and is chair of multiple committees. She is also past President of The Dermatologic Society of Greater New York, President of the New York State Society of Dermatology and Dermatologic Surgery, and Founding Editor in Chief of JAAD Reviews.Dr. Lipner is board certified in Dermatology and has a wide range of clinical experience in the diagnosis and management of skin, hair, and nail disorders. She is one of the few experts in nail disorders in the world, and treats patients with nail psoriasis, nail fungal diseases, brittle nails, and nail cancers. She is also the Primary Investigator on clinical trials utilizing novel treatments for nail disorders, and offers alternative treatments to patients who have failed traditional therapies. She is also an expert in telemedicine and can diagnosis many patients with nail disorders using a video platform.Dr. Lipner is one of the leading researchers in dermatology. She has authored over 400 peer-reviewed publications, numerous books and book chapters, lectures nationally and internationally, and is frequently featured by the media including, CNN, NPR, Self, Allure, The Washington Post, and The New York Times for her expertise. Dr. Lipner offers aesthetic therapies such as Botox and injectable fillers, laser therapy for the treatment of rosacea, broken blood vessels, age spots and hair removal in both fair-skinned patients and patients with skin of color. To schedule an appointment, please call 646-962-DERM (3376).

Care Philosophy: Hyun-Soo Lee, M.D grew up in Korea and Flushing. He graduated from Yale University in 1983 and the State University of New York at Stony Brook, School of Medicine in 1990. He completed the internship in internal medicine at Albert Einstein College of Medicine in 1991 and the residency in dermatology at New York University School of Medicine in 1994. He stayed at New York University for a dermatopathology fellowship until 1995. Dr Lee is a Diplomate of American Board of Dermatology for Dermatology and American Board of Pathology for Dermatopathology. He is a fellow of the American Academy of Dermatology. He was a Clinical Assistant Professor of Dermatology at New York University School of Medicine.

Biography: Dr. Blank graduated summa cum laude from the University of Pennsylvania and received her medical degree from Weill Cornell Medical College, where she was inducted into the Alpha Omega Alpha honors society. She completed her medical internship at Memorial Sloan-Kettering Cancer Center. She returned to Weill Cornell Medical College for her dermatology residency, where she served as chief resident during her final year and received a Distinguished Housestaff Award for all-around excellence. Dr. Blank sees adult patients for general dermatologic concerns and has particular clinical interests in complex medical dermatology, cutaneous drug reactions and infections, and cutaneous manifestations of internal disease. Dr. Blank also serves as a dermatology inpatient consultant at both NewYork-Presbyterian Hospital - Cornell and NewYork-Presbyterian - Lower Manhattan Hospital.

Care Philosophy: "Better people means better experiences. Our care team is committed to delivering results that change lives."

Biography: Dr. Barbara T. Ma, is an Assistant Professor of Medicine at Weill Cornell Medicine and an Assistant Attending Physician at New York Presbyterian Hospital. Dr. Ma graduated with B.S. in Biomedical Engineering and M.S. in Biotechnology from Johns Hopkins University. She received her medical degree from New York Medical College. She completed her internal medicine training at Georgetown University Hospital and fellowship in Hematology/Oncology at NewYork-Presbyterian Hospital/Weill Cornell Medicine, where she also served as a chief fellow. Dr. Ma cares for patients with skin cancers, including melanoma. Her research focus is optimizing immunotherapy treatments for solid tumor patients with special interest on immunotherapy toxicities. She heads the Phase I unit and leads Cellular Therapy for Solid Tumors at Cornell. Dr. Ma is a recipient of the American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award. She is a member of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), Golden Humanism Honor Society (GHHS), and Society for Immunotherapy and Translational Research in Cancer.

Care Philosophy: I treat every patient as a valued member of my family. My mission is to provide my patients with quality medical care and an exceptional healthcare experience.

Care Philosophy: I realize how scary it can be to receive a life-threatening diagnosis, and firmly believe in taking the time to clearly communicate with my patients about the nature of their disease and their various treatment options. This can not only vastly improve our patients' experiences, but also their treatment outcomes, as an educated patient is able to make informed decisions about care and reclaim some of the autonomy that can be lost when coping with a cancer diagnosis. In the midst of all the cutting-edge science and technology that we offer, I find it extremely important to remember that it is the patient who is the center of it all. I genuinely care about my patients, and instilling a sense of hope, sharing a laugh, or a kind word can be as important as all the medical advances and state-of-the-art science.

Biography: Dr. Cora Sternberg is a leading international researcher and world expert in the field of medical oncology, genitourinary (GU) cancers, and drug development. As a key opinion leader in three different types of genitourinary cancers, Dr. Sternberg isknown for her influential work in developing novel therapies and targeted agents for the treatment of prostate, renal and bladder cancers.Dr. Sternberg helped develop the original M-VAC chemotherapy regimen, as well as the double-dose/high-dose/accelerated-dose M-VAC chemotherapy regimens in bladder and urothelial cancers. These treatments are the gold standard, saving many lives and decreasing suffering in patientswith these diseases.Additionally, Dr. Sternberg has served as principal investigator or been involved in numerous practice-changing studies for prostate cancer. These research efforts have led to the FDA approvals of abiraterone acetate and enzalutamide in advanced prostate cancer. Most recently, her publication in the New England Journal of Medicine (NEJM) demonstrated dramatic improvements in metastasis-free survival (MFS) in men with castration resistant prostate cancer (CRPC) without evidence of metastatic disease, but at high risk of developing metastases, a population for whom there were previously no approved therapeutics. This research led to the approval of enzalutamide in the M0 CRPC patient population.Dr. Sternberg has been instrumental in the development of the drug Pazopanib, an antiangiogenic targeted therapy, for advanced clear cell renal cell carcinoma. Dr. Sternberg served as lead investigator in the large phase 3 international study that demonstrated the efficacy, safety and tolerability of this drug in patients with metastatic kidney cancer, culminating in the FDA approval. She has also participated in the development of other antiagiogenic agents such as sunitinib, cabozantinib, tivozanib and dovitinib to treat renal cell cancer.At Weill Cornell Medicine and NewYork-Presbyterian Hospital, Dr. Sternberg will facilitate the continued growth and development of clinical and translational research programs in genitourinary (GU) malignancies, with a particular emphasis on expanding the breadth and depth of clinical and translational research. AsClinical Director of the Englander Institute for Precision Medicine (EIPM), Dr. Sternberg will develop strategies to incorporate genomic sequencing and precision medicine throughout the Weill Cornell Medicine and NewYork-Presbyterian healthcare network, including Lower Manhattan, Brooklyn and Queens. In addition to providing her clinical and research expertise in genitourinary oncology, Dr. Sternberg will work closely with Olivier Elemento, PhD, renowned computational biologist and Director of the EIPM, to develop novel strategies and apply precision oncology to optimize cancer prevention, detection and treatment across a variety of tumor types.Dr. Sternberg previously served as Chief of the Department of Medical Oncology at the San Camillo-Forlanini Hospital in Rome, Italy, and adjunct Professor of Oncology at La Sapienza University in Rome. A graduate of the University of Pennsylvania undergraduate and medical schools, Dr. Sternberg completed her fellowship and previously was on staff at Memorial Sloan Kettering Cancer Center.Dr. Sternberg has published approximately 400 articles in peer-reviewed publications,including more than 100 first-authored articles. She has co-edited six textbooks, guest edited six others, and has published over 80 book chapters. Dr. Sternberg has lectured extensively at universities and cancer symposia worldwide, having given approximately 750 invited talks atprestigious international venues.Throughout her career, she has served on the editorial boards of Critical Reviews in Hematology and Oncology, Annals of Oncology, and the Journal of Clinical Oncology, and she currently serves on the editorial boards of Oncology, European Urology, the Harvard Medical School Annual Report on Prostate Diseases, Kidney Cancer, Nature Clinical Practice Urology, and European Urology Oncology. Dr. Sternberg also serves as Reviewer for the New England Journal of Medicine, the Journal of Clinical Oncology, the Lancet Oncology and others.She currently serves as the Solid Tumor Editor for Critical Reviews in Hematology and Oncology, Section Editor for Urologic Oncology, Associate Editor for Bladder Cancer Clinical Trials Corner, Associate Editor and Genitourinary Oncology Editor for ESMO Open-Cancer Horizons, and Associate Editor for Frontiers in Oncology. Additionally, Dr. Sternberg previously served as Oncology Editor for the British Journal of Urology, Section Editor for Urologic Oncology, and Genitourinary Editor for the European Journal of Cancer.Dr. Sternberg's leadership in the field is further exemplified by the numerous international committees on which she has served. She was elected to three consecutive terms as Board Member and Executive Board Member of the European Organization for Research and Treatment of Cancer (EORTC) and elected to the nominating committee of the American Society of Clinical Oncology (ASCO) board of directors, currently serving a 3-year term.This document has been edited with the instant web content composer which can be found at htmleditor.tools - give it a try.

Care Philosophy: At Moffitt Cancer Center, we are working tirelessly in the areas of patient care, research and education to advance one step further in fighting cancer. As a National Cancer Institute-designated Comprehensive Cancer Center, we are committed to the health and safety of our patients and dedicated to providing expert cancer care. From enhanced quality of life to complete remission, Moffitt is Florida's top choice aiming to achieve the best outcome for each patient.

Biography: Dr. Feldman is an Assistant Professor of Medicine in the Division of Cardiology of the Department of Medicine at Weill Cornell Medical College and an Attending Physician at New York Presbyterian-Weill Cornell Medical Center.Dr. Feldman grew up in Framingham, Massachusetts and completed her undergraduate studies at the University of Pennsylvania. She earned her medical degree from Boston University School of Medicine, completed Internal Medicine residency at Beth Israel Deaconess Medical Center/Harvard Medical School, where she completed the Clinician Educator Track, fellowship in Cardiovascular Disease at Boston Medical Center/Boston University School of Medicine, and an additional fellowship in Cardio-Oncology at Memorial Sloan Kettering Cancer Center. After training, she founded and directed the Cardio-Oncology and Cardiac Amyloidosis programs at Rutgers New Jersey Medical School/University Hospital. In 2023, she joined the Cardiology Division at New York-Presbyterian/Weill Cornell Medical College as a full-time faculty member where she provides expertise in cardio-oncology, cardiac imaging, and medical education. She serves as the Director of the Cardio-Oncology program.Dr. Feldman is board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, Nuclear Cardiology, and Cardio-Oncology. She is a fellow of the American College of Cardiology, and a member of the American Heart Association, American Society of Nuclear Cardiology, and the International Society of Cardio-Oncology.

Biography: Dr. Jini Hyun is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine and Attending Physician at New York-Presbyterian Queens (NYPQ). After obtaining her Masters of Science in Pharmacology and Pharmacognosy at the Seoul National University in 2001, Dr. Hyun performed research at the University of Illinois at Chicago before obtaining her medical degree from St. George's University in 2013.She was a rotating resident at the National Heart, Lung and Blood Institute in 2015. In 2017, Dr. Hyun completed an internal medicine residency at NewYork-Presbyterian Queens where she also served as Chief Resident. Following residency, Dr. Hyun completed her hematology and medical oncology fellowship training at SUNY Downstate Medical Center where she held the title of Chief Fellow. Dr. Hyun is part of the Hematology and Medical Oncology team at NYPQ and is accepting new patients.